Anthocyanin Rich Extract (ACRE) in Patients With Ulcerative Colitis
Status:
Completed
Trial end date:
2021-03-11
Target enrollment:
Participant gender:
Summary
This study evaluates the efficacy and safety of a bilberry derived anthocyanin-rich extract
in patients with ulcerative colitis. Two thirds of participants will receive the
anthocyanin-rich extract, while one third will receive placebo, for 8 weeks of treatment.
Phase:
Phase 2
Details
Lead Sponsor:
University of Zurich
Collaborators:
Swiss National Science Foundation The Broad Foundation